Cholesterol treatment guidelines have evolved in the United States from the 1988 Adult Treatment Panel (ATP) I, the ATP II guidelines, ATP III guidelines, the 2013 American College of Cardiology/American Heart Association guidelines, to the most recent 2016 recommendations from the United States ...
Consequently, most clinicians discontinue statins upon suspicion of dengue infection and restart them only after recovery. A recent randomized controlled trial of Vietnamese adult dengue patients compared lovastatin versus placebo and did not find an increase in adverse events. However, the trial ...
Data collected included age, most recent CD4+ cell count and viral load, ARV history, and all fasting cholesterol, triglyceride, high-density lipoprotein (HDL), and low-density lipoprotein (LDL) values. The ARV therapy at the time of lipid readings was classified as including protease inhibitors...
The National Cholesterol Education Panel (NCEP) created a standard using lipid levels in 2001 that is still the most commonly used clinical classification (Table 1).2The NCEP is currently revising its recommendations with an updated version of ATP-III guidelines expected to be released in the autu...
hyperlipidemialow‐density lipoprotein cholesterolproprotein convertase subtilisin/kexin type 9Current guidelines for hypercholesterolemia treatment emphasize lifestyle ... MK Ito,RD Santos - 《Journal of Clinical Pharmacology》 被引量: 15发表: 2017年 Proprotein convertase subtilisin/kexin type 9 (PCSK9) in...
Hyperlipidemia plays an important role in the etiology of cardio-cerebrovascular disease. Over recent years, a number of studies have explored the impact of apolipoprotein genetic polymorphisms in hyperlipidemia, but considerable differences and uncertai
Adult Treatment Panel III (ATP III) of the National Cholesterol Education Program, ATP III Update (2004) Implications of recent clinical trials for the ATP III guidelines. http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3upd04.htm Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen...
Most Viewed Current Articles 17 Jan 2024 :Review article6,968,210 Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant DOI :10.12659/MSM.942799 Med Sci Monit 2024; 30:e942799 0:00 16 May 2023 :Clinical Research701,772 ...
While male and female have some small numerical differences in the percentage of population reaching target goal of therapy, it cannot be determined at this time if this is a true difference, an artifact of the imprecise risk factor classification of the NCEP guidelines, difference in drug ...
This review summarizes the data from these recent publications, in addition to briefly summarizing the pharmacology of inclisiran and the trials that resulted in the initial approval of inclisiran.14 Inclisiran is a small interfering RNA. In the liver, inclisiran directs the catalytic breakdown...